UPDATE 2-Regeneron beats second-quarter profit estimates on Eylea boost
August 06, 2019 at 08:32 AM EDT
Regeneron Pharmaceuticals Inc beat analysts' estimates for second-quarter profit and revenue on Tuesday, boosted by double-digit sales growth of its blockbuster treatment Eylea in the United States.
